Nektar Therapeutics

IRS: 943134940
NKTR
Nektar Therapeutics

Nektar Therapeutics is a San Francisco-based emerging biotechnology company specializing in PEGylation technology.

Founded
1990 (31 years)
CEO
Howard W. Robin
Investor RelationsSEC
Revenue
163 million (2020)

Want to see more? Sign up!